AnPac Bio-Medical Science Co., Ltd.
ANPC · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $61,721 | $105,437 | $386,981 | $772,853 |
| - Cash | $1,870 | $9,251 | $3,016 | $6,125 |
| + Debt | $12,314 | $33,759 | $8,232 | $38,568 |
| Enterprise Value | $72,165 | $129,945 | $392,197 | $805,296 |
| Revenue | $12,044 | $17,986 | $20,509 | $10,845 |
| % Growth | -33% | -12.3% | 89.1% | – |
| Gross Profit | $8,336 | $12,254 | $12,881 | $4,798 |
| % Margin | 69.2% | 68.1% | 62.8% | 44.2% |
| EBITDA | -$99,618 | -$112,097 | -$77,413 | -$93,347 |
| % Margin | -827.1% | -623.2% | -377.5% | -860.7% |
| Net Income | -$103,598 | -$120,087 | -$80,565 | -$101,621 |
| % Margin | -860.2% | -667.7% | -392.8% | -937% |
| EPS Diluted | -54.18 | -176.53 | -143.99 | -205.96 |
| % Growth | 69.3% | -22.6% | 30.1% | – |
| Operating Cash Flow | -$55,060 | -$71,709 | -$58,967 | -$48,600 |
| Capital Expenditures | -$1,592 | -$3,973 | -$2,492 | -$3,161 |
| Free Cash Flow | -$56,652 | -$75,682 | -$61,459 | -$51,761 |